Directed endodermal differentiation of murine embryonic stem (ES) cells gives rise to a subset of cells with a hepatic phenotype. Such ES cell-derived hepatic progenitor cells (ES-HPC) can acquire features of hepatocytes in vitro, but fail to form substantial hepatocyte clusters in vivo. In this study, we investigated whether this is due to inefficient engraftment or an immature phenotype of ES-HPC. ES cells engrafted into recipient livers of NOD/SCID mice with a similar efficacy as adult hepatocytes after 28 days. Because transplanted unpurified ES-HPC formed teratomas in the spleen and liver, we applied an albumin promoter/enhancerdriven reporter system to purify ES-HPC by cell sorting. RT-PCR analyses for hepatocyte-specific genes showed that the cells exhibited a hepatic phenotype, lacking the expression of the pluripotency marker Oct4, comparable to cells of day 11.5 embryos. Sorted ES-HPC derived from β-galactosidase transgenic ES cells were injected into fumaryl-acetoacetate-deficient (FAH −/− ) SCID mice and analyzed after 8 to 12 weeks. Staining with X-gal solution revealed the presence of engrafted cells throughout the liver. However, immunostaining for the FAH protein indicated hepatocyte formation at a very low frequency, without evidence for large hepatocyte cluster formation. In conclusion, the limited repopulation capacity of ES-HPC is not caused by a failure of primary engraftment, but may be due to an immature hepatic phenotype of the transplanted ES-HPC.
INTRODUCTION
nificant progress has been made in identifying factors and developing protocols to enforce the differentiation of ES cells into cells of the hepatocyte lineage (5,6,9-Several stem cell sources have been studied extensively for their potential to differentiate into cells of the 12, 15, 17, 23, 35, 40, 41) . Hamazaki and coworkers were among the first to generate a high percentage of hepato-hepatic phenotype in the last years (1, 8, 22, 25, 29, 31, 33, 34, 37) . However, most of the currently available data cyte precursors from murine ES cell cultures in the presence of growth factors (10). Miyashita et al. (23) and indicate that somatic cell types have a limited capacity to generate liver tissue (3, 16, 36) in transplantation ex-Kania et al. (17) subsequently published differentiation protocols that direct the maturation of the primitive ES periments. Embryonic stem (ES) cells can be maintained in a state of pluripotency for long periods of time, and cells toward cells with a distinct and mature hepatic phenotype, and result in a high percentage of ES-HPC in can be grown in large numbers (2, 18, 28) . Spontaneous differentiation of ES cells can be achieved through the culture. In addition, bone morphogenetic protein (BMP) 4 has recently been identified to mediate an important formation of embryoid bodies (EB) and subsequent inoculation of the EB-derived cells on adherent matrices signal in the development of cells with a hepatic phenotype from ES cells (9) . facilitates differentiation into hepatocyte-like cells in the presence of a variety of growth factors, cytokines, and However, hepatocyte formation after transplantation of ES-HPC into fumaryl-acetoacetate-deficient (FAH −/− ) hormones, such as hepatocyte growth factor (HGF), fibroblast growth factor (FGF), and dexamethasone. Sig-mice was much lower than that previously reported for transplanted primary adult hepatocytes. In this particular Isolation of Mouse Primary Hepatocytes and Fetal Liver Tissue study, only in one out of seven transplanted mice few ES-HPC-derived hepatocytes could be detected (9) . The Primary adult hepatocytes were isolated using a twouroplasminogen-activator transgenic MUP-uPA/SCID step collagenase perfusion method (32). Livers from femouse is a highly artificial model for metabolic liver tuses at day 11.5 and 13.5 were isolated and applied to disorders, but to date it is the only one that clearly indi-RNA isolation as previously described (13). cates the potential for cellular therapies (11). Neverthe-Transplantation and Distribution Analysis of ES Cells less, the rate of hepatocyte and liver tissue formation and Primary Hepatocytes again was much lower than that previously reported for transplanted adult hepatocytes or fetal hepatoblasts (4) .
ES cells and primary adult hepatocytes were incu-The reduced efficacy of hepatocyte and liver tissue forbated with the PKH26 fluorescent dye (Sigma) for 10 mation may have been due to lower primary engraftment min and washed to remove excess dye. Cells (5 × 10 5 ) rates of the ES-HPC into the recipient liver, incomplete (viability >80% by trypan blue exclusion) were transdifferentiation, or a combination of both.
planted via the intrasplenic route into the liver of NOD/ Therefore, we first evaluated the primary engraftment SCID mice. After 24 h, 48 h, 14 days, and 28 days the rate of ES after transplantation, before, in a second set livers (n = 4 for each time point) native PKH26 fluoresof experiments, we analyzed the developmental stage cence analysis was analyzed on cryosections (10 µm). and the repopulation capacity of ES-HPC in FAH mice.
Autofluorescence was excluded by parallel examination of the red (617 nm) and green emission (528 nm). The
MATERIALS AND METHODS
numbers of PKH-fluorescent engrafted ES cells and pri-Animals mary adult hepatocytes were assessed in 20 high power fields (200×) of 10 representative sections. NOD/SCID mice were obtained from The Jackson Laboratories (Bar Harbour, ME, USA) and cross-bred to Lentiviral Vector Production C57BL/6FAH −/− mice to obtain FAH −/− /SCID animals.
A multiple cloning site (MCS) for the insertion of the The drinking water was supplemented with 2-(2-nitro-4hepatocyte-specific promoters/enhancer sequence was trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC, cloned into the pRRL.PPT.PGK.GFPpre vector (7), 7.5 ml/L). All animals were maintained and handled in kindly provided by L. Naldini (Milano, Italy). The proaccordance with institutional guidelines. moter/enhancer fragment of the 2.3-kb albumin promoter/enhancer sequence [kindly provided by Dr. Pal-Embryonic Stem Cell Culture miter (27) ] was excised with NotI, blunted with Klenow Embryonic stem (ES) cells of the line E14 (24) or polymerase, and cloned into the EcoRV-opened lentividerived from Rosa26 mice were cultivated on mouse ral vector pRRL.PPT.MCS.GFPpre to obtain the RRL. embryonic fibroblasts on gelatinized dishes (Falcon BD) PPT.Alb.GFPpre vector. Lentiviral supernatant producin culture medium I (Knock-out DMEM, Invitrogen) tion was performed as described previously (30) . supplemented with 15% FCS (selected batches) and additives: β-mercaptoethanol (5 × 10 −5 M), L-glutamine (2 Lentiviral Transduction of ES-HPC mM), nonessential amino acids, penicillin-streptomycin On day 31 (day 5 + 9 + 17) of differentiation, ES-(all Invitrogen), and 10 ng/ml recombinant human leu-HPC were transduced with the lentivirus vector RRL. kemia inhibitory factor (LIF, Chemicon) as described PPT.Alb.GFPpre (MOI ϳ10) and analyzed for EGFP previously (39). fluorescence after 3 days with a fluorescence microscope. After visual analysis, the cells were trypsinized Differentiation of Mouse ES Cells Into Hepatic and sorted for EGFP in a MoFlow cytometer.
Progenitor Cells
Gene Expression Analysis For hepatic differentiation, 600 ES cells were cultivated in hanging drops (20 µl) as described previously Isolation of total RNA from sorted ES-HPC and firststrand cDNA synthesis was performed as described pre- (17) to form embryoid bodies (EBs). On day 5, EBs were plated onto gelatinized dishes in culture medium II viously (13). Expression of various mRNAs was analyzed by standard PCR. All PCR products were sequenced (IMDM, Invitrogen) supplemented with 20% FCS, 450 µM α-monothioglycerol (Sigma), and all additives except and found to be identical to the published cDNA sequences. All primers span intron/exon boundaries to pre-LIF. On days 5 + 9, EB outgrowths were trypsinized, replated onto collagen type I-coated dishes in differentiation vent amplification from residual genomic DNA. Primer sequences (Table 1) for RT-PCR were chosen for an medium (hepatocyte culture medium, Cambrex), and cultivated until days 5 + 9 + 20.
annealing temperature of 55°C. 
Real-Time RT-PCR cells) of PKH26-labeled hepatocytes and ES cells were
injected into the spleen of NOD/SCID mice (n = 24; 3 Albumin mRNA expression normalized to the house mice per cell type and time point). Twenty-four hours keeping gene GAPDH was measured by real-time RTafter the injection, many of the cells were detected in PCR with the iCycler System (BIO-RAD) using the the sinusoidal spaces of the liver in both experimental iCycler iQ Real-Time Detection System Software (Vergroups. The hepatocyte-transplanted mice showed larger sion 2.1) as described previously (14).
clusters of PKH26-labeled cells embolizing the sinusoids ( Fig. 1a ), whereas the ES-transplanted group showed a Transplantation of ES-HPC in FAH −/− /SCID Mice more widespread distribution of single cells ( Fig. 1d ).
Sorted ES-HPCs from Rosa26-derived ES cells (0.5-
The total number of PKH26-labeled cells per high-1 × 10 5 ) were transplanted into FAH −/− /SCID mice (age power magnification (200×) field in the ES-transplanted 6-8 weeks) through the spleen. This was accompanied group was slightly lower after 24 and 48 h compared to by repeated cycles of alternating NTBC supplementation that of the hepatocyte-transplanted group (Fig. 1c , f). At and withdrawal from the animals' drinking water.
28 days postinjection, roughly one PKH26-labeled cell per viewing field could be observed, which had invaded Staining Procedures the liver plates (0.32 ± 0.39 ES-derived cells vs. 1.55 ± Hematoxylin and eosin (H&E) staining was per-1.05 hepatocytes; p > 0.05). This demonstrates for the formed according to standard protocols. For detection of first time that ES-derived cells can enter the liver plates FAH-positive cells, formalin-fixed and paraffin-embedand engraft into the liver with a similar efficacy as ded tissues were sliced into 4-µm sections, deparaffinadult hepatocytes in a nonselective transplantation setized in xylene, and rehydrated in a decreasing ethanol ting. However, all ES cell-transplanted mice, which row. After epitope retrieval, nonspecific staining was were analyzed after 28 days, suffered from teratoma blocked with normal goat serum (3%) for 15 min, before formation. incubation with the FAH primary antibody (1:100, 60 min, I G nex, Portland). After application of the secondary Transplantation of In Vitro Differentiated ES-HPC antibody (goat anti-rabbit, 1:400, 30 min, Vector Labs), ES-HPC (day 5 + 9 + 20) from Rosa26 mouse-derived color development was performed with the 3-amino-9-ES were transplanted into NOD/SCID mice (1 × 10 6 ethylcarbazole (AEC) chromogen system (Zymed). cells, n = 10) to investigate liver repopulation capabilities after 4, 8, and 12 weeks ( Table 2) . For an additional RESULTS proliferation stimulus two thirds partial hepatectomy Liver Engraftment of ES-Derived Cells was performed 2 days after the cell transplantation. None of the mice showed bona fide engraftment of he-First we addressed the question of whether the engraftment efficiency of ES cells is similar to that of pri-patic cells, but teratoma formation occurred in the spleen (injection site) and in the liver ( 
mice. Cryosections of the tumors stained with H&E
Selection of ES-Derived Hepatic Precursor Cells indicated the presence of multiple cell types of mesodermal, ectodermal, and endodermal origin (Fig. 2b, c) .
To avoid teratoma formation after transplantation, we constructed, in a second experiment, a lentivirus vector However, no teratoma was observed in the lungs or other organs, suggesting that the transplanted cells had that expressed EGFP (enhanced green fluorescent protein) under the transcriptional control of the albumin engrafted in the livers without spreading and without undergoing metastasis (data not shown).
promoter/enhancer sequence (Fig. 3a) to enable cell type-specific purification. For control experiments, we designed a similar vector with the ubiquitously expressed phosphoglycerate-kinase (PGK) promoter. Transduction of several cell lines of hepatic and nonhepatic origin indicated the liver lineage-specific expression of EGFP from the albumin promoter/enhancer construct (data not shown). Three days after transduction, we estimated a transfection efficiency for the PGK-EGFP transfected cells of about 50% (Fig. 3d, e ). Following transfection with the albumin-EGFP construct fluorescence was observed in large cells with morphological characteristics of hepatoblasts (Fig. 3b, c) . No fluorescence was detected in high-density clusters of small cells, presumably consisting of undifferentiated ES cells. Single cell suspensions of ES-HPC were generated by trypsinization on day 5 + 9 + 20 to perform fluorescence-activated cell sorting. With a stringent gating strategy, a pure albumin-EGFP-positive ES-HPC population could be isolated (Fig. 4) . The gating conditions excluded cells with weak albumin-EGFP expression, as well as autofluorescent cells to avoid contamination with undifferentiated teratoma-forming cells. This strategy led to fractions of albumin-EGFP high ES-HPC between 1.92% (Fig. 4b ) and 4.66% of albumin-EGFP high cells.
Hepatic Gene Expression Profile of Albumin-EGFP high ES-HPC
Gene expression profiling of albumin-EGFP high ES-HPC was performed to determine the cells' hepatoblastic phenotype and to demonstrate the absence of undifferentiated ES cells. The hepatic marker genes albumin, α-fetoprotein, CK-18, and CK-8 were present in the sorted ES-HPC, but the pluripotency-associated tran- EGFP high ES-HPC was ϳ0.2% of that of adult hepato- cytes and within the range of the expression of day 11.5 (TTR), tyrosine aminotransferase (TAT), and CYP2b13. The hepatic nuclear factor (HNF) 3β was constantly ex-and day 13.5 fetal liver tissue. Additional RT-PCR analyses of hepatic genes (Fig. 5d ) demonstrated stronger pressed as well as β-tubulin (TUB). signals of early expressed genes as α-fetoprotein (AFP)
Transplantation of Purified ES-HPC Into FAH −/− Mice and nestin in sorted ES-HPC compared to adult liver and weaker signals of genes expressed in mature hepatocytes Albumin-EGFPhigh ES-HPC (5 × 10 4 , derived from Rosa26 ES cells, were transplanted into FAH −/− /SCID as albumin (ALB), α1-antitrypsine (AAT), transthyretin mice, which were challenged with repeated cycles of (14 and 28 days), both transplanted primary hepatocytes, as well as the ES-derived cells, were still detected in the supplementation and withdrawal of NTBC. Eight to 12 weeks after transplantation, no teratoma tissue was ob-recipient liver, with a frequency that could be expected in a nonselective transplantation setting. served in the mice, indicating efficient selection of ES-HPC from the ES culture. Staining for β-galactosidase Directed in vitro differentiation of ES cells may overcome the risk of teratoma formation and promote the expression revealed the presence of numerous transplantation-derived cells in the recipient livers (Fig. 6a, b) , formation of somatic cell types (9, 11, 20) . In our first transplantation experiments, however, most of the NOD/ distributed throughout the liver as single cells or as small clusters of 2 to 4 cells, but we did not observe SCID mice developed teratomas within 8 to 12 weeks after transplantation ( Table 2 ). Similar transplantation larger regeneration nodules, which can regularly be detected after transplantation of primary hepatocytes. Fi-experiments were performed in the uPA-transgenic mouse liver repopulation model, demonstrating accelerated ter-nally, the liver tissue was analyzed by immunohistochemistry of the FAH enzyme. No signal was found in atoma formation in the spleen and liver within a 3-week period (data not shown). liver sections of untransplanted FAH −/− mice (data not shown), but single cells or small clusters of FAH-posi-To eliminate residual undifferentiated ES cells from cell suspensions for transplantation, strategies have been tive cells could be observed in ES-HPC transplanted animals ( Fig. 6d ). Careful analysis of multiple liver sec-developed to purify the ES-derived progenitor cells (19) . In our second experiment, we established a hepatic lin-tions demonstrated several small nodules, but failed to demonstrate a relevant repopulation of the host liver, eage-specific cell sorting technique by lentivirus vectormediated expression of the green fluorescent protein which could rescue the metabolic deficiency in this particular animal model.
(EGFP) under the transcriptional control of the albumin promoter/enhancer sequence in differentiating cells. In DISCUSSION our hands, the published hepatic differentiation protocols (14,17) yielded a hepatic precursor subpopulation In transplantation experiments, the generation of therapeutically significant numbers of functional hepato-of about 20% after day 5 + 9 + 20. Because for a robust expression of lentiviral transduced EGFP a time span of cytes and of therapeutically functional liver tissue from ES-HPC is required. Also needed is the engraftment of 3 days is reported, we transduced our ES-HPC on the stage of day 5 + 9 + 17. Kania et al. reported typical he-the cells into the recipient liver, an adequate response to proliferation signals and the differentiation into an adult patic gene expression profiles already at earlier stages (e.g., day 5 + 9 + 10) (17) , but in or hands the ES-HPC hepatic phenotype. In our first experiment we demonstrate, for the first time, that ES-derived cells home and of later stages resemble more a hepatoblasts phenotype.
Considering that roughly 50% of the cells (Fig. 3d ) got engraft with a similar, or slightly lower, efficiency as primary adult hepatocytes ( Fig. 1) . At later time points transfected, we estimated that 10% of ES-HPC expressed albumin-EGFP. To avoid any cross-contamination with such as Oct4, indicating efficient elimination of undifferentiated ES cells. Quantitative gene expression data undifferentiated ES cells, we applied very stringent sorting conditions to gate-out nonspecific fluorescent cells.
indicated that our differentiation protocol induced an early fetal hepatic phenotype in the sorted ES-HPC. The This resulted in a sorted fraction between 4.66% and 1.92% (Fig. 4b ). Because the latter preparation was albumin mRNA expression reached levels of embryonic day 11.5-13.5 fetal mouse liver tissue. Because fetal liv-transplanted into the FAH −/− mouse, as presented in Figure 6d , we chose this particular preparation for presenta-ers contain multiple nonhepatic cells, their albumin mRNA is diluted compared with that of sorted ES-HPC. For tion in Figure 4 .
The stringently sorted ES-HPC expressed liver-specific this reason we staged the albumin expression (0.67-fold GAPDH expression) of our ES-HPC comparable to the genes and lacked expression of pluripotency markers, expression of day 11.5 fetuses (0.14-fold GAPDH ex-supplementation could not be terminated. In another study, Heo et al. transplanted purified ES-HPC into the pression). In addition, we compared expression of early and late hepatic genes in sorted ES-HPC and adult liver liver of MUP-uPA/SCID mice and demonstrated hepatocyte cluster formation averaging only 1.94% of the liver cells (Fig. 3d ). These data confirm previous studies from our laboratory (14) and from others (5,6,9-12,15,23, mass (11) . But the rate of hepatocyte and liver tissue formation after ES-HPC transplantation was much lower 35, 40, 41) , demonstrating that most, if not all, ES-HPC lack maturation towards an adult hepatic phenotype. than that reported for transplanted primary adult hepatocytes (26) or fetal hepatoblasts (4) in previous studies, Recently, Gouon-Evans et al. transplanted a subpopulation of ES-HPC into FAH −/− mice and found one clus-suggesting that current protocols are not sufficient to obtain ES-HPC with therapeutic implications. ter of FAH-positive cells in only 1 out of 7 mice, indicating incomplete repopulation by ES-HPC in that With respect to the origin of the FAH-positive cells in the recipient livers, the low number and the small size highly selective liver repopulation model (9) . Compared to these data, the results of our experiments show a sig-of the FAH-positive clusters after ES-HPC transplantation do not support the hypothesis that those clusters nificant improvement, as we were able to detect single hepatocytes or small clusters of hepatocytes in each of may be a product of cell fusion between ES cell-derived cells and endogenous hepatocytes, because fusion-derived the five transplanted FAH −/− /SCID mice (Fig. 6 ). The engrafted cells exhibit a mature phenotype and are func-regeneration nodules proliferate quite fast, as shown in recent publications (21,38) and very few, perhaps less tionally integrated in the liver of the recipient mice. However, the number of engrafted cells was not suffi-than 100 cells, are sufficient for the repopulation of large parts of the FAH mouse liver. cient to rescue the disease phenotype and the NTBC 
